Table 3.

Multivariable Analysis for Prediction of Primary and Secondary Outcome

	Primary Outcome				Secondary Outcome
	Clinical Model		Clinical Model + CMR		Clinical Model		Clinical Model + CMR
	Statistic	p-value	Statistic	p-value	Statistic	p-value	Statistic	p-value
Harrell’s Cstatistic	0.715	--	0.765	0.02*	0.678	--	0.716	0.03*
Covariates	HR (95% CI)		HR (95% CI)		HR (95% CI)		HR (95% CI)
Age	1.03 (1.01–1.05)	0.004	1.02 (1.01–1.04)	0.01	1.02 (1.01–1.03)	0.002	1.02 (1.00–1.03)	0.008
Female	0.62 (0.38–1.00)	<0.05	0.72 (0.44–1.19)	0.20	0.81 (0.58–1.12)	0.21	0.93 (0.66–1.31)	0.67
Diabetes mellitus	1.90 (1.25–2.88)	0.003	1.56 (1.02–2.39)	0.04	1.69 (1.24–2.29)	0.001	1.40 (1.02–1.91)	0.04
History of MI	2.27 (1.50–3.43)	<0.001	1.39 (0.88–2.19)	0.16	1.68 (1.22–2.31)	0.001	1.14 (0.81–1.61)	0.45
History of CHF	1.76 (1.12–2.75)	0.01	1.83 (1.1702.86)	0.008	1.30 (0.94–1.81)	0.12	1.31 (0.95–1.82)	0.10
LVEF (per +5% ∆)	0.96 (0.86–1.06)	0.39	1.00 (0.98–1.02)	0.99	0.89 (0.83–0.97)	0.005	0.92 (0.85–0.99)	0.03
Ischemia	--		2.63 (1.68–4.14)	<0.001	--		2.14 (1.55–2.95)	<0.001
LGE	--		1.86 (1.05–3.29)	0.03	--		1.70 (1.16–2.49)	0.007

^*Compared to Clinical Model